HCSG

Business Context and Reporting Period

Company: Healthcare Services Group, Inc. (HCSG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: HCSG provides management, administrative, and operating services to housekeeping, laundry, linen, facility maintenance, and dietary departments for healthcare facilities, primarily long-term care providers (nursing homes, rehabilitation centers, hospitals). The company operates two segments: Housekeeping and Dietary.

Key Financial Metrics

Note: Working Capital calculated as Total Current Assets ($573,212) minus Total Current Liabilities ($209,483).

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenues increased 1.8% for the quarter and 1.6% for the six-month period compared to 2023. Dietary segment revenue grew 3.1% (quarter) and 3.6% (six months), while Housekeeping revenue remained flat (0.1% increase) or declined slightly (0.7% decrease) due to facility count changes offset by cost pass-throughs.
• Profitability Decline: Net income for the six months ended June 30, 2024, decreased 32.1% to $13.5 million from $19.9 million in the prior year. The company reported a net loss of $1.8 million for the quarter, compared to a net income of $8.3 million in the prior year quarter.
• Bad Debt Provision: A significant increase in bad debt provision occurred due to the Chapter 11 bankruptcy of customer LaVie Care Centers, LLC. The company increased its allowance for doubtful accounts by $17.6 million in the second quarter of 2024.
• Operating Expenses: Costs of services provided increased 4.5% for the quarter and 1.8% for the six months. Selling, general, and administrative (SG&A) expenses increased 7.3% for the quarter and 12.1% for the six months, driven by payroll, legal, and transportation costs, partially offset by favorable adjustments to self-insurance reserves ($5.1 million).
• Cash Flow: Net cash used in operating activities was $9.7 million for the six months ended June 30, 2024, primarily due to an increase in accounts receivable.

Guidance, Outlook, and Risks

• Outlook: Management expects to continue obtaining service agreements with new customers and retaining existing ones. They aim to achieve modest price increases and maintain internal cost reduction strategies. Capital expenditures for 2024 are estimated between $5.0 million and $7.0 million.
• Customer Concentration: Genesis Healthcare, Inc. accounted for 9.0% of consolidated revenues for the six months ended June 30, 2024. No other single customer exceeded 10%.
• Key Risks:
  • Credit Risk: Significant exposure to the financial health of long-term care providers, many of whom rely on Medicare/Medicaid reimbursements. The LaVie bankruptcy highlights collection risks.
  • Regulatory & Labor: Risks related to changes in healthcare regulations, minimum wage increases, and labor shortages in the nursing home sector.
  • Internal Controls: Management previously identified a material weakness regarding accrued payroll liabilities (vacation accruals). While remediation measures were implemented in the first half of 2024, the company noted that internal control over financial reporting was not effective as of June 30, 2024, due to the prior weakness.
• Unusual Items: The $17.6 million bad debt charge related to LaVie is a non-recurring event impacting current period profitability. Additionally, the company recorded a favorable $5.1 million adjustment to self-insurance reserves.

Investor Verification Checklist

• LaVie Bankruptcy Impact: Verify the extent of ongoing exposure to LaVie Care Centers and the adequacy of the $17.6 million allowance for doubtful accounts.
• Customer Concentration: Monitor the financial stability of Genesis Healthcare, Inc., which represents nearly 10% of revenue.
• Internal Control Remediation: Confirm the effectiveness of the new controls regarding vacation accruals in future filings to ensure the material weakness is fully resolved.
• Cash Flow Trends: Analyze the trend in accounts receivable days sales outstanding (DSO) given the negative operating cash flow and increased bad debt provisions.
• Debt Covenants: Review compliance with the $300 million line of credit covenants (Funded debt to EBITDA ratio of 0.95 and EBITDA to Interest Expense ratio of 8.52 as of June 30, 2024).